The expression of HSPA5 and IGF2R in liver cancer tissue and their relationship with clinical pathological features and prognoses
摘要
目的 探讨肝癌患者癌组织中热休克蛋白A5(HSPA5)、胰岛素样生长因子2受体(IGF2R)表达与临床病理特征和预后的关系.方法 纳入2021年4月至2022年4月河南大学第一附属医院治疗的145例肝癌患者,收集其癌组织和癌旁组织,同时记录微血管侵犯、TNM分期、巴塞罗那(BCLC)分期等临床病理特征及3年生存情况,根据是否生存进一步分为生存组和死亡组.采用CPTAC数据库检索肝细胞癌组织中HSPA5、IGF2R表达情况.采用免疫组化法检测肝癌组织、癌旁组织HSPA5、IGF2R表达情况;采用Kaplan-Meier法分析肝癌组织中HSPA5、IGF2R表达水平与预后的关系;采用Cox回归分析筛选肝癌患者预后的影响因素.结果 检索CPTAC数据库发现,肝细胞癌组织中,HSPA5表达与正常肝组织差异无统计学意义(P>0.05),而IGF2R表达高于正常肝组织(P<0.05).免疫组化染色结果显示,肝癌组织中HSPA5、IGF2R阳性表达率高于癌旁组织(P<0.05).HSPA5、IGF2R阳性表达患者有微血管侵犯、TNM Ⅲ~Ⅳ期、组织低分化、BCLC C~D期比例高于阴性表达患者(P<0.05).HSPA5、IGF2R阳性表达患者3年生存率(57.45%、58.49%)显著低于阴性表达患者(80.39%、84.62%)(P<0.05).死亡组TNM Ⅲ~Ⅳ期、组织低分化、BCLC C~D期比例高于生存组(P<0.05).HSPA5 阳性表达(HR=2.978,95%CI:1.578~5.620)、IGF2R 阳性表达(HR=3.054,95%CI:1.373~6.795)、TNM Ⅲ~Ⅳ 期(HR=3.015,95%CI:1.393~6.526)是肝癌患者 3年内死亡的独立影响因素(P<0.05).结论 HSPA5、IGF2R在肝癌组织中高表达,二者与微血管侵犯、TNM分期、组织分化程度、BCLC分期及预后相关.
Objective To explore the relationships between the expression of heat shock protein A5(HSPA5),insulin-like growth factor 2 receptor(IGF2R)in liver cancer patients and their clinical pathological features and prognoses.Methods From April 2021 to April 2022,145 liver cancer patients in the First Affiliated Hospital of Henan University were included.Their liver cancer tissues and paracancerous tissues were collected,and the clinicopathological characteristics such as microvascular invasion,TNM staging,Barcelona clinic liver cancer(BCLC)staging and the 3-year survival rate were recorded.The liver cancer patients were further divided into a survival group and a death group.The CPTAC database was used to retrieve the expression of HSPA5 and IGF2R in liver cancer tissues.Immunohistochemistry was performed to detect the HSPA5 and IGF2R expressions in tissues.Kaplan-Meier method was used to explore the relationship between the HSPA5 and IGF2R expression in liver cancer tissues and prognoses.Cox regression analysis was used to screen for the prognostic factors of patients with liver cancer.Results The research of the CPTAC database revealed that the expression of HSPA5 in liver cancer tissue was not significantly different from that in normal liver tissue(P>0.05),while the expression of IGF2R was significantly higher than that in normal liver tissue(P<0.05).The immunohistochemical staining results showed that the positive expression rates of HSPA5 and IGF2R in liver cancer tissue were higher than those in paracancerous tissues(P<0.05).Patients with positive expression of HSPA5 and IGF2R had higher proportions of microvascular invasion,TNM stage Ⅲ~Ⅳ,poor tissue differentiation,and BCLC stage C~D compared with those with negative expression(P<0.05).Liver cancer patients with positive expression of HSPA5 and IGF2R proteins(57.45%,58.49%)had prominently lower 3-year survival rate than that of patients with negative expression(80.39%,84.62%)(P<0.05).The death group had higher proportions of TNM stage Ⅲ~Ⅳ,poor tissue differentiation,and BCLC stage C~D than that in the survival group(P<0.05).Positive expression of HSPA5(HR=2.978,95%CI:1.578~5.620),IGF2R(HR=3.054,95%CI:1.373~6.795)and TNM stage Ⅲ~Ⅳ(HR=3.015,95%CI:1.393~6.526)were independent influencing factors for 3-year mortality in patients with liver cancer(P<0.05).Conclusion HSPA5 and IGF2R are highly expressed in liver cancer tissue,and they are related to microvascular invasion,TNM staging,tissue differentiation degree,BCLC staging,and prognosis.